Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00235053Phase 4Completed
Phase 4, open-label, single-arm trial of fluticasone propionate in asthma, sponsored by Allergy & Asthma Medical Group & Research Center. Primary endpoint: Voice Handicap Index. Started Aug 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00235053.